In Brief: International Remote Imaging Systems
This article was originally published in The Gray Sheet
International Remote Imaging Systems: Anticipates late 1996 launch of its White IRIS high-speed leukocyte differential analyzer, IRIS President and CEO Fred Deindoerfer announced at a Jan. 17 session of the American Stock Exchange health care conference in New York City. A 510(k) for the device, which shares 80% of its components with the firm's Yellow IRIS urinalysis workstation, was submitted in July 1995. FDA clearance of the firm's 900UDx urine pathology system, co-developed with Boehringer Mannheim ("The Gray Sheet" Sept. 4, 1995, p. 6), is anticipated by the end of the second quarter...
You may also be interested in...
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.